Key result
Transplant pharmacist discharge reconciliation linked to ~68% fewer medication errors at first clinic visit.
Why the study?
Solid-organ transplant recipients are at increased risk for medication errors during transitions of care, particularly at discharge, necessitating evaluation of pharmacist involvement to improve safety.
Does transplant pharmacist involvement reduce medication errors at discharge in solid-organ transplant recipients?
Observational (n=192)
Does transplant pharmacist involvement reduce medication errors at discharge in solid-organ transplant recipients?
Transplant pharmacist involvement in discharge medication reconciliation significantly reduces medication errors in solid-organ transplant recipients.
Answers are grounded in this paper and cite their sources.
May reduce discharge medication errors in transplant recipients; leaves open need for randomized trials on clinical outcomes.
Greater than 50% of medication errors are estimated to occur during transitions of care, and solid-organ transplant recipients are at an increased risk for errors due to significant changes in their medication regimen following transplantation. This prospective, observational study with a historical control group was conducted to evaluate the discharge process for transplant recipients and determine if transplant pharmacist involvement would improve safety. During the prospective period, a total of 191 errors were made on discharge medication reconciliations (n = 64, mean rate 3.0 per patient); however, pharmacists prevented 119 of these errors (1.9 errors per patient). In the retrospective period, none of the 430 errors identified were prevented at the time of discharge (n = 128, p < 0.0001). The 72 errors not prevented at the time of discharge in the prospective cohort were identified by the pharmacist at the patient's first clinic visit (1.1 errors per patient). In the historical cohort, all 430 errors made at discharge persisted until at least the time of the first clinic visit (3.4 errors per patient, p < 0.0001). This study demonstrates that transplant recipients are at a high risk for medication errors and that transplant pharmacist involvement leads to improved safety through the significant reduction of medication errors.
No takes yet. Share an insight, caveat, or question.
Musgrave et al. (2013) conducted an observational in Solid-organ transplant (n=192). Transplant pharmacist discharge medication reconciliation vs. Historical control group was evaluated on Medication errors persisting until the first clinic visit (p=<0.0001). Transplant pharmacist discharge medication reconciliation reduced medication errors persisting until the first clinic visit compared to historical controls.
Synapse has enriched 10 related papers. Consider them for comparative context: